School of Psychology, Keele University, Keele ST5 5BG, UK.
Division of Biosciences, University College London, London WC1E 6DE, UK.
Vaccine. 2023 Feb 17;41(8):1438-1446. doi: 10.1016/j.vaccine.2023.01.027. Epub 2023 Jan 29.
To explore acceptability of and preferences for the introduction of varicella vaccination to the UK childhood immunisation schedule.
We conducted an online cross-sectional survey exploring parental attitudes towards vaccines in general, and varicella vaccine specifically, and their preferences for how the vaccine should be administered.
596 parents (76.3% female, 23.3% male, 0.4% other; mean age 33.4 years) whose youngest child was aged 0-5 years.
Willingness to accept the vaccine for their child and preferences for how the vaccine should be administered (in combination with the MMR vaccine [MMRV], on the same day as the MMR vaccine but as a separate injection [MMR + V], on a separate additional visit).
74.0% of parents (95% CI 70.2% to 77.5%) were extremely/somewhat likely to accept a varicella vaccine for their child if one became available, 18.3% (95% CI 15.3% to 21.8%) were extremely/somewhat unlikely to accept it and 7.7% (95% CI 5.7% to 10.2%) were neither likely nor unlikely. Reasons provided by parents likely to accept the vaccine included protection from complications of chickenpox, trust in the vaccine/healthcare professionals, and wanting their child to avoid their personal experience of chickenpox. Reasons provided by parents who were unlikely included chickenpox not being a serious illness, concern about side effects, and believing it is preferable to catch chickenpox as a child rather than as an adult. A combined MMRV vaccination or additional visit to the surgery were preferred over an additional injection at the same visit.
Most parents would accept a varicella vaccination. These findings highlight parents' preferences for varicella vaccine administration, information needed to inform vaccine policy and practice and development of a communication strategy.
探索英国儿童免疫计划中引入水痘疫苗的可接受性和偏好。
我们进行了一项在线横断面调查,探讨了父母对一般疫苗接种的态度,以及对水痘疫苗的具体看法,以及他们对疫苗接种方式的偏好。
596 名父母(76.3%女性,23.3%男性,0.4%其他;平均年龄 33.4 岁),其最小的孩子年龄为 0-5 岁。
愿意为孩子接种疫苗以及对疫苗接种方式的偏好(与麻疹、腮腺炎、风疹联合疫苗[MMRV]联合接种,与 MMR 疫苗同一天接种,但作为单独注射[MMR+V],在单独的额外访问中接种)。
74.0%的父母(95%置信区间 70.2%至 77.5%)非常/有些可能会为孩子接种水痘疫苗,如果有一种疫苗可用,18.3%(95%置信区间 15.3%至 21.8%)非常/有些不太可能接受,7.7%(95%置信区间 5.7%至 10.2%)既不倾向也不反对。愿意接种疫苗的父母提供的原因包括保护免受水痘并发症的影响、对疫苗/医疗保健专业人员的信任、以及希望孩子避免自己感染水痘的经历。不太可能接种疫苗的父母提供的原因包括水痘不是一种严重的疾病、担心副作用、以及认为儿童感染水痘比成年后感染更好。联合 MMRV 疫苗接种或到诊所额外就诊比在同一就诊时增加注射更受欢迎。
大多数父母都会接受水痘疫苗接种。这些发现突出了父母对水痘疫苗接种方式的偏好,这是为疫苗政策和实践提供信息以及制定沟通策略的必要条件。